Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Characterisation and intervention in long-term nasal decongestant overuse
2024-516312-25-00Phase 4Completed
- Sponsor
- Ghent University Hospital
- Start
- Sep 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of mometasone in rhinitis medicamentosa (RM) (2 arms), sponsored by Ghent University Hospital. Primary endpoints: Complete withdrawal from nasal decongestants and Relapse of nasal decongestant overuse. Started Sep 2024; status: completed.
02
Drugs
mometasone
03
Conditions
rhinitis medicamentosa (RM)
Beyond the preview
Go deeper on 2024-516312-25-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-516312-25-00.